Kinetics of the LOV domain of ZEITLUPE determine its circadian function in Arabidopsis
- Southern Methodist University, United States
- University of Washington, United States
- Ohio State University, United States
- RIKEN Center for Sustainable Resource Science, Japan
Abstract
A LOV (Light, Oxygen, or Voltage) domain containing blue-light photoreceptor ZEITLUPE (ZTL) directs circadian timing by degrading clock proteins in plants. Functions hinge upon allosteric differences coupled to the ZTL photocycle; however, structural and kinetic information was unavailable. Herein, we tune the ZTL photocycle over two orders of magnitude. These variants reveal that ZTL complexes with targets independent of light, but dictates enhanced protein degradation in the dark. In vivo experiments definitively show photocycle kinetics dictate the rate of clock component degradation, thereby impacting circadian period. Structural studies demonstrate that photocycle dependent activation of ZTL depends on an unusual dark-state conformation of ZTL. Crystal structures of ZTL LOV domain confirm delineation of structural and kinetic mechanisms and identify an evolutionarily selected allosteric hinge differentiating modes of PAS/LOV signal transduction. The combined biochemical, genetic and structural studies provide new mechanisms indicating how PAS/LOV proteins integrate environmental variables in complex networks.
Data availability
-
Structure and kinetics of the LOV domain of ZEITLUPE determine its circadian function in ArabidopsisPublicly available at the RCSB Protein Data Bank (accession no: 5SVG).
-
Structure and kinetics of the LOV domain of ZEITLUPE determine its circadian function in ArabidopsisPublicly available at the RCSB Protein Data Bank (accession no: 5SVU).
-
Structure and kinetics of the LOV domain of ZEITLUPE determine its circadian function in ArabidopsisPublicly available at the RCSB Protein Data Bank (accession no: 5SVV).
-
Light-state Structure of Arabidopsis Thaliana ZeitlupePublicly available at the RCSB Protein Data Bank (accession no: 5SVW).
Article and author information
Author details
Funding
National Institutes of Health (R15GM109282)
- Brian D Zoltowski
Herman Frasch Foundation for Chemical Research (739-HF12)
- Brian D Zoltowski
Rural Development Administration (PJ011175)
- Young Hun Song
- Takato Imaizumi
National Science Foundation (MCB 1613643)
- Brian D Zoltowski
National Institutes of Health (R01GM079712)
- Takato Imaizumi
National Institutes of Health (R01GM093285)
- David E Somers
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Copyright
© 2017, Pudasaini et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 4,699
- views
-
- 898
- downloads
-
- 57
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Kinetics of the LOV domain of ZEITLUPE determine its circadian function in Arabidopsis
eLife 6:e21646.
https://doi.org/10.7554/eLife.21646
Further reading
-
- Biochemistry and Chemical Biology
- Structural Biology and Molecular Biophysics
African trypanosomes are the causative agents of neglected tropical diseases affecting both humans and livestock. Disease control is highly challenging due to an increasing number of drug treatment failures. African trypanosomes are extracellular, blood-borne parasites that mainly rely on glycolysis for their energy metabolism within the mammalian host. Trypanosomal glycolytic enzymes are therefore of interest for the development of trypanocidal drugs. Here, we report the serendipitous discovery of a camelid single-domain antibody (sdAb aka Nanobody) that selectively inhibits the enzymatic activity of trypanosomatid (but not host) pyruvate kinases through an allosteric mechanism. By combining enzyme kinetics, biophysics, structural biology, and transgenic parasite survival assays, we provide a proof-of-principle that the sdAb-mediated enzyme inhibition negatively impacts parasite fitness and growth.
-
- Structural Biology and Molecular Biophysics
The relationship between protein dynamics and function is essential for understanding biological processes and developing effective therapeutics. Functional sites within proteins are critical for activities such as substrate binding, catalysis, and structural changes. Existing computational methods for the predictions of functional residues are trained on sequence, structural, and experimental data, but they do not explicitly model the influence of evolution on protein dynamics. This overlooked contribution is essential as it is known that evolution can fine-tune protein dynamics through compensatory mutations either to improve the proteins’ performance or diversify its function while maintaining the same structural scaffold. To model this critical contribution, we introduce DyNoPy, a computational method that combines residue coevolution analysis with molecular dynamics simulations, revealing hidden correlations between functional sites. DyNoPy constructs a graph model of residue–residue interactions, identifies communities of key residue groups, and annotates critical sites based on their roles. By leveraging the concept of coevolved dynamical couplings—residue pairs with critical dynamical interactions that have been preserved during evolution—DyNoPy offers a powerful method for predicting and analysing protein evolution and dynamics. We demonstrate the effectiveness of DyNoPy on SHV-1 and PDC-3, chromosomally encoded β-lactamases linked to antibiotic resistance, highlighting its potential to inform drug design and address pressing healthcare challenges.
